Peptides and related molecules that modulate nerve growth factor activity

Details for Australian Patent Application No. 2011226786 (hide)

Owner Amgen Inc.

Inventors Boone, Thomas C.; Wild Jr., Kenneth D.; Sitney, Karen C.; Min, Hosung; Kimmel, Bruce

Agent Shelston IP

Pub. Number AU-A-2011226786

Parent 2008201194

Filing date 21 September 2011

Wipo publication date 13 October 2011

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 October 2011 Application Open to Public Inspection

  Published as AU-A-2011226786

13 October 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011226787-Biogenic fuel gas generation in geologic hydrocarbon deposits

2011226785-Power Monitoring and Signal Unit